...
首页> 外文期刊>American Journal of Physiology >Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice.
【24h】

Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice.

机译:植物乳杆菌可通过调节IL-10基因敲除小鼠的顶端连接复合物和PepT1改善结肠上皮屏障功能障碍。

获取原文
获取原文并翻译 | 示例

摘要

Probiotics are efficacious in the treatment of inflammatory bowel disease. However, the precise mechanisms remain unknown. To determine whether probiotic Lactobacillus plantarum (LP) ameliorates colonic epithelial barrier dysfunction present in interleukin-10 knockout (IL-10(/)) mice, IL-10(/) and wild-type mice received LP or the vehicle for 4 wk. Colitis was assessed by histological scores and clinical manifestation, and gut paracellular permeability was measured by Ussing chamber. Oligopeptide transporter 1 (PepT1)-mediated transepithelial transport was evaluated by measuring the plasma cephalexin concentration. The expression and distribution of apical junctional complex (AJC) proteins and PepT1 were determined by Western blotting and immunofluorescence and their mRNA by reverse transcriptase-PCR. Spontaneous colitis was observed in all IL-10(/) mice in which paracellular permeability was increased, in conjunction with decreased expression and redistribution of zonula occludens-1, occludin, claudin-1, and beta-catenin. PepT1 expression was increased, accompanied with an enhanced cephalexin transport. Colonic epithelial barrier dysfunction was further confirmed by increased bacterial translocation and proinflammatory cytokine production. Treatment with LP decreased colonic paracellular permeability with restoration of expression and distribution of AJC proteins and partially prevented PepT1 expression and cephalexin transport in IL-10(/) mice. Moreover, treatment with LP also prevented bacterial translocation and proinflammatory cytokine production in IL-10(/) mice. Results from this study indicated that treatment with LP may ameliorate colonic epithelial barrier dysfunction in IL-10(/) mice, by modulating the AJC- and PepT1-mediated transepithelial transport.
机译:益生菌对炎症性肠病有效。但是,确切的机制仍然未知。为了确定益生菌植物乳杆菌(LP)是否能改善白介素10基因敲除(IL-10(/))小鼠中存在的结肠上皮屏障功能障碍,IL-10(/)和野生型小鼠接受LP或载剂持续4周。通过组织学评分和临床表现评估结肠炎,并通过Ussing chamber测量肠道副细胞通透性。通过测量血浆头孢氨苄浓度评估寡肽转运蛋白1(PepT1)介导的上皮转运。 Western blotting和免疫荧光法检测AJC蛋白和PepT1的表达和分布,逆转录PCR法检测其mRNA的表达。在所有IL-10(/)小鼠中均观察到自发性结肠炎,其中细胞旁通透性增加,同时小带闭合蛋白1,闭合蛋白,claudin-1和β-catenin的表达和重新分布减少。 PepT1表达增加,并伴有增强的头孢氨苄转运。细菌上位增加和促炎细胞因子产生进一步证实了结肠上皮屏障功能障碍。 LP治疗可降低结肠副细胞通透性,恢复AJC蛋白的表达和分布,并部分阻止IL-10(/)小鼠中PepT1表达和头孢氨苄转运。此外,用LP治疗还可以防止IL-10(/)小鼠中细菌移位和促炎细胞因子的产生。这项研究的结果表明,通过调节AJC和PepT1介导的上皮运输,用LP治疗可以改善IL-10(/)小鼠的结肠上皮屏障功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号